Detailed Information for C01141

Basic information about inhibitors

IPAD-DB ID C01141
Name Berberine
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 2 0 H 1 8 N O 4 +
Molecular Weight 336.4 g/mol
IUPAC Name 16, 17-dimethoxy-5, 7-dioxa-13-azoniapentacyclo[11.8.0.02, 10.04, 8.015, 20]henicosa-1(13), 2, 4(8), 9, 14, 16, 18, 20-octaene
InChI InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4, 7-10H, 5-6, 11H2, 1-2H3/q+1
InChIKey YBHILYKTIRIUTE-UHFFFAOYSA-N
Canonical SMILES COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC
PubChem CID 2353
DrugBank Accession Number DB04115
CAS Registry Number 2086-83-1

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein Tau protein
Effects Reverse deficits of learning and memory in TgCRND8 mice, mitigate Aβ pathology and Aβ levels in TgCRND8 mice, alter APP processing, APP, and tau phosphorylation probably through inhibition of Akt/GSK3 activities in TgCRND8 mouse brain
Research Models In TgCRND8 mice, in N2a-SwedAPP cell
Main Source Rhizoma coptidis
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 336.36
Hac(Computed by SwissADME) 25
Volume(Computed by ADMETlab 2.0) 338.078
Density(Computed by ADMETlab 2.0) 0.994
nRing(Computed by ADMETlab 2.0) 5
MaxRing(Computed by ADMETlab 2.0) 21
nHet(Computed by ADMETlab 2.0) 5
fChar(Computed by ADMETlab 2.0) 1
nRig(Computed by ADMETlab 2.0) 25
Flexibility(Computed by ADMETlab 2.0) 0.08
Stero Centers(Computed by ADMETlab 2.0) 0
LogS(Computed by ADMETlab 2.0) -6.311
LogD(Computed by ADMETlab 2.0) 3.482

ADMET properties

logP(Computed by ADMETlab 2.0) 3.1
TPSA(Computed by SwissADME) 40.80 Ų
Hbond Acceptor(Computed by SwissADME) 4
Hbond Donor(Computed by SwissADME) 0
Rotatable Bonds(Computed by SwissADME) 2

Pharmacokinetics

GI Absorption(Computed by SwissADME) High
BBB(blood-brain barrier) Permeant(Computed by SwissADME) Yes
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) Yes
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) Yes
CYP3A4 Inhibitor(Computed by SwissADME) Yes
log Kp(Skin Permeation)(Computed by SwissADME) -5.78 cm/s

Druglikeness

Lipinski(Computed by SwissADME)
Ghose(Computed by SwissADME)
Veber(Computed by SwissADME)
Egan(Computed by SwissADME)
Muegge(Computed by SwissADME)
Bioavailability Score(Computed by SwissADME)